osimertinib
astrazeneca
['adaura', 'reassure', 'nsclc', 'sclc', 'osimertinib']
adaura:
3 yrs of adjuvant osimertinib for individuals with resected stage ib-iiia nsclc improved survival need to see paper to be reassured that most patients on placebo arm accessed osi if they recurred. if so then the only barrier to treatment would be its cost.
#asco23
Dad/hubby|PhD|Med onc@Nepean|@MOGA_ORG Chair|USyd Lecturer|Interests: GI/lung cancer|value|decision making|fin tox|Luv the Rabbitohs & Dr Who|Opinions = mine